Leukemia Lymphoma Articles & Analysis
13 articles found
It allows for the simultaneous detection of gene rearrangements and the expression of corresponding proteins, helping in the characterization of specific subtypes of leukemia and lymphoma. Furthermore, it sheds light on the interplay between genetic abnormalities and protein expression, offering insights into potential therapeutic targets. ...
This method, known as CAR-T cell therapy, has shown remarkable success in treating certain types of leukemia and lymphoma, offering a potential cure where traditional therapies have failed. ...
In healthcare, clonality analysis is crucial in the diagnosis, prognosis, and treatment planning of cancers, particularly leukemia and lymphomas. By mapping the clonal architecture of tumors, healthcare providers can make informed decisions regarding treatment options and predict patient outcomes. ...
In healthcare, clonality analysis is crucial in the diagnosis, prognosis, and treatment planning of cancers, particularly leukemia and lymphomas. By mapping the clonal architecture of tumors, healthcare providers can make informed decisions regarding treatment options and predict patient outcomes. ...
Diseases Associated with CD19 CD19 is implicated in various significant diseases, including: 1) B-Cell Lymphoma: B-cell lymphoma, a type of leukemia and lymphoma arising from lymphoid tissue, shows overexpression of CD19 on the surface of B cells in certain patients. ...
Expression of anti-CD19 chimeric signaling receptors can enhance NK-cell reactivity against CD19+ leukemia and lymphoma cells. Here we describe a method to enforce expression of such receptors in human NK cells relying on electroporation of mRNA and compare it to retroviral transduction of cDNA. ...
Although CAR-T therapy has revolutionized the treatment of hematological diseases such as leukemia and lymphoma, it has not translated into similar success in solid tumors. ...
The receptors on the surface of CAR-T cells can act as a GPS, looking for special markers on the surface of cancer cells; a variety of CAR-T cell therapies have been approved for the treatment of patients with leukemia, lymphoma and multiple myeloma, but there are currently no CAR-T cell therapies approved for the treatment of solid tumors. ...
In 2017, CAR-T therapy was first approved by the FDA for the treatment of blood cancers such as leukemia and lymphoma. The successful application of CAR-T therapy has renewed hope for many desperate people, who are waiting for bone marrow matching. ...
As part of the research agreement, OLO will collect images of around 150 samples that span across approximately 10 different types of leukemia and lymphoma. “A major piece of information that we obtain from these samples is a clinical diagnosis — what type of cancer it is,” Bringoltz says. ...
Patents are pending in psoriasis and autoimmune diseases, including uveitis, cytokine storm, and preventing the recurrence of leukemia and lymphoma. ...
IL-2, approved by the FDA and several European countries, is a potent cytokine that is known to boost the immune system in patients fighting cancers such as malignant melanoma, renal cell cancer, leukemias and lymphomas. "Our study highlights the importance of age as a factor when designing cell-based or pharmacological therapies for older patients, and it ...
Besides diabetes and insulin resistance, exposure to chlordane compounds have been linked to a variety of symptoms (headache, lethargy, upper respiratory infections), human cancers (prostate, breast, testicular, leukemia, lymphoma), and chronic diseases (allergies, anxiety, depression, Parkinson, Crohn’s disease). ...